Development, testing and approval of vaccines for the prevention of covid-19

Many clinical trials of covid-19 vaccines are currently under way. Norway is working closely with the EU to facilitate rapid and efficient vaccine development and authorisation, without compromising requirements for documentation.

Medicines agencies around the world are in close dialogue with research scientists and pharmaceutical companies that are developing vaccines against covid-19. This also applies to the European Medicines Agency (EMA), to which Norway is affiliated. The EMA has set up a Pandemic Task Force (COVID-ETF), which is responsible for the rapid coordination of resources and the provision of support to various research projects being carried out within the EU. The EMA is also working closely with the World Health Organization (WHO).

The approval process for covid-19 vaccines

The various vaccine technologies

Reported suspected adverse reactions of covid-19 vaccines